Publication & Citation Trends
Most Cited Works
Publications
82 total
Postinduction molecular MRD identifies patients with <i>NPM1</i> AML who benefit from allogeneic transplant in first remission PDF
Cited by 72
OpenAlex
Molecular, clinical, and therapeutic determinants of outcome in <i>NPM1</i>-mutated AML PDF
Cited by 72
OpenAlex
Molecular MRD is strongly prognostic in patients with <i>NPM1</i>-mutated AML receiving venetoclax-based nonintensive therapy PDF
Cited by 62
OpenAlex
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial PDF
Cited by 52
OpenAlex
Pretransplant <i>FLT3</i>-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome PDF
Cited by 79
OpenAlex
Molecular MRD status and outcome after transplantation in NPM1-mutated AML PDF
Cited by 163
OpenAlex
Research Topics
Acute Myeloid Leukemia Research
(52)
Acute Lymphoblastic Leukemia research
(28)
Chronic Myeloid Leukemia Treatments
(19)
Cancer Genomics and Diagnostics
(19)
Glioma Diagnosis and Treatment
(12)
Frequent Co-Authors
Affiliations
University of Wolverhampton
Guy's Hospital
European Bioinformatics Institute
University of British Columbia
Institute of Cancer Research